The Drug Enforcement Administration's Toxicology Testing Program (DEA TOX) published a Quarter 3 2022 report summarizing findings from July...
Reports
This report provides up-to-date information regarding the drug supply in Philadelphia, Pennsylvania.
The objective of this report is to provide updated guidance in developing an appropriate analytical scope of testing for...
The cannabis plant contains more than a hundred chemical compounds known as cannabinoids, including the more commonly known cannabidiol...
LAPPA provides general information about both the Overdose Detection and Mapping Application Program (ODMAP) developed by Washington/Baltimore HIDTA (W/B...
NDEWS Hotspot Alerts November 3 – November 9, 2022: Opioid, heroin, methamphetamine, and non-opioid 911 dispatches
Lisa McElhaney / /This week's NDEWS Hotspot Alerts report includes 5 counties with higher-than-expected drug-related 911 dispatch counts over the previous 7-day period.
The Substance Abuse and Mental Health Services Administration (SAMHSA) is pleased to announce the release of the agency’s Interim...
The report presents drug testing results from 8 sites across the US for Quarter 3 2022, including geographical differences...
NDEWS Hotspot Alerts October 27 – November 2, 2022: Opioid, heroin, methamphetamine, and non-opioid 911 dispatches
Lisa McElhaney / /In this week's NDEWS Hotspot Alerts report, 21 counties in 9 states were identified as having above-expected counts for...
A Joint Intelligence Report from the Drug Enforcement Administration (DEA) details the presence and dangers of xylazine in an...
Trending Reports
- Trend Reports: cfsre NPS – Q1 2024 April 13, 2024
- NDEWS State Report: Alerts in New ork for 2023 April 12, 2024
- Federal Register: Placement of Etodesnitazene, NPyrrolidino Etonitazene, and Protonitazene in Schedule I April 11, 2024
- Federal Register: Extension of Temporary Placement of Butonitazene, Flunitazene, and Metodesnitazene in Schedule I April 11, 2024
- NDEWS Hotspot Alerts March 21 – 27, 2024 April 5, 2024